GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (FRA:7CA) » Definitions » Price-to-Owner-Earnings

Camurus AB (FRA:7CA) Price-to-Owner-Earnings : 88.48 (As of May. 16, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Camurus AB Price-to-Owner-Earnings?

As of today (2024-05-16), Camurus AB's share price is €47.78. Camurus AB's Owner Earnings per Share (TTM) ended in Mar. 2024 was €0.54. It's Price-to-Owner-Earnings for today is 88.48.


The historical rank and industry rank for Camurus AB's Price-to-Owner-Earnings or its related term are showing as below:

FRA:7CA' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 40.82   Med: 187.7   Max: 717.78
Current: 89.03

During the past 13 years, the highest Price-to-Owner-Earnings of Camurus AB was 717.78. The lowest was 40.82. And the median was 187.70.


FRA:7CA's Price-to-Owner-Earnings is ranked worse than
78.92% of 166 companies
in the Biotechnology industry
Industry Median: 34.09 vs FRA:7CA: 89.03

As of today (2024-05-16), Camurus AB's share price is €47.78. Camurus AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €0.67. Therefore, Camurus AB's PE Ratio for today is 71.42.

As of today (2024-05-16), Camurus AB's share price is €47.78. Camurus AB's EPS without NRI for the trailing twelve months (TTM) ended in was €0.67. Therefore, Camurus AB's PE Ratio without NRI for today is 71.42.

During the past 13 years, Camurus AB's highest PE Ratio without NRI was 550.61. The lowest was 38.70. And the median was 70.83.


Camurus AB Price-to-Owner-Earnings Historical Data

The historical data trend for Camurus AB's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camurus AB Price-to-Owner-Earnings Chart

Camurus AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 330.57 78.35

Camurus AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 171.45 580.50 40.21 78.35 80.61

Competitive Comparison of Camurus AB's Price-to-Owner-Earnings

For the Biotechnology subindustry, Camurus AB's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Camurus AB's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camurus AB's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Camurus AB's Price-to-Owner-Earnings falls into.



Camurus AB Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Camurus AB's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=47.78/0.54
=88.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Camurus AB  (FRA:7CA) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Camurus AB Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Camurus AB's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Camurus AB (FRA:7CA) Business Description

Industry
Traded in Other Exchanges
Address
Ideon Science Park, Lund, SWE, SE-223 70
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The company's product pipeline includes CAM2038, CAM2029, CAM2032, and others. The company's geographical revenue includes Europe (of which Sweden), the United States of America, Australia, and Other geographical areas.

Camurus AB (FRA:7CA) Headlines

No Headlines